Allworth Financial’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Allworth Financial’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1	Closed	-$5	–	3452
2023 Q1	$5	Buy	+1	New	+$5	﹤0.01%	3168

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Allworth Financial's CTIC Position: Q2 2023 in Review

Allworth Financial sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 1 share — an estimated $5 sold.

Allworth Financial first reported a position in CTIC in Q1 2023 and held it in 1 quarter. The position peaked at $5 in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

Allworth Financial reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
Allworth Financial sold 1 CTI BioPharma Corp. (DE) Common Stock share in Q2 2023, an estimated $5.
Allworth Financial first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2023 and held it in 1 quarter.
Allworth Financial's CTI BioPharma Corp. (DE) Common Stock position peaked at $5 in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on Allworth Financial's 13F filing for Q2 2023, filed 18 Jul 2023.